We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+17%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.33B
AUM Growth
+$1.78B
Cap. Flow
+$552M
Cap. Flow %
5.91%
Top 10 Hldgs %
20.52%
Holding
814
New
78
Increased
378
Reduced
271
Closed
33

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$50.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$39.4M
3
INTC icon
Intel
INTC
+$29.2M
4
QCOM icon
Qualcomm
QCOM
+$27.6M
5
DHR icon
Danaher
DHR
+$26M

Top Sells

Rank Stock Value
1
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$49.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$41.6M
3
ARQL
Arqule Inc
ARQL
+$26.5M
4
ARWR icon
Arrowhead Research
ARWR
+$24.9M
5
MRK icon
Merck
MRK
+$15.4M

Sector Composition

Rank Sector Weight
1 Healthcare 30.73%
2 Technology 19.55%
3 Financials 10.18%
4 Consumer Discretionary 9.32%
5 Communication Services 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NOV icon
676
NOV
NOV
$7.45B
$755K 0.01%
30,126
-17,451
-37% -$393K
MDRX
677
DELISTED
Veradigm Inc. Common Stock
MDRX
$736K 0.01%
75,000
– –
BMY.RT
678
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$736K 0.01%
+244,618
New +$636K
QTRX icon
679
Quanterix
QTRX
$173M
$733K 0.01%
31,000
– –
SWX icon
680
Southwest Gas
SWX
$6.74B
$723K 0.01%
9,523
– –
PBYI icon
681
Puma Biotechnology
PBYI
$406M
$719K 0.01%
82,200
-141,000
-63% -$1.17M
WUBA
682
DELISTED
58.com Inc
WUBA
$712K 0.01%
11,000
-400
-4% -$22.5K
PNQI icon
683
Invesco NASDAQ Internet ETF
PNQI
$501M
$694K 0.01%
24,500
-2,450
-9% -$65.9K
SE icon
684
Sea Limited
SE
$61.2B
$684K 0.01%
17,000
+9,000
+113% +$303K
NTR icon
685
Nutrien
NTR
$32.7B
$678K 0.01%
14,152
-184,004
-93% -$8.89M
SIRI icon
686
SiriusXM
SIRI
$10B
$677K 0.01%
9,471
+2,708
+40% +$182K
DELL icon
687
Dell
DELL
$283B
$673K 0.01%
25,821
+859
+3% +$22.3K
NWL icon
688
Newell Brands
NWL
$2.16B
$673K 0.01%
35,034
+2,330
+7% +$44.9K
BBWI icon
689
Bath & Body Works
BBWI
$4.01B
$667K 0.01%
45,540
-54,318
-54% -$784K
APO icon
690
Apollo Global Management
APO
$70.7B
$664K 0.01%
+13,895
New +$593K
RCI icon
691
Rogers Communications
RCI
$17.7B
$650K 0.01%
13,063
+2,130
+19% +$103K
ABMD
692
DELISTED
Abiomed Inc
ABMD
$640K 0.01%
3,752
-2,330
-38% -$432K
TPR icon
693
Tapestry
TPR
$28.8B
$631K 0.01%
23,405
-755
-3% -$19.7K
MOMO
694
Hello Group
MOMO
$869M
$626K 0.01%
18,700
+3,700
+25% +$132K
FNV icon
695
Franco-Nevada
FNV
$41.4B
$623K 0.01%
6,023
+2,604
+76% +$252K
GL icon
696
Globe Life
GL
$13.5B
$620K 0.01%
+5,889
New +$587K
SONY icon
697
Sony
SONY
$123B
– –
0
– –
DXC icon
698
DXC Technology
DXC
$1.63B
$607K 0.01%
16,151
-6,759
-30% -$220K
SPY icon
699
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$598K 0.01%
1,065
-41
-4% -$12.6K
VALE icon
700
Vale
VALE
$62.9B
$570K 0.01%
43,160
+18,104
+72% +$218K
26 27
28
29 30

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2019 Portfolio in Review

As of Q4 2019, Candriam SCA held 814 positions worth $9.33B, up 24% from $7.55B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA deployed $552M of net new capital in Q4 2019, opening 78 new positions and adding to 378 existing holdings. Its largest new stake was Vipshop: 2,005,000 shares worth $28.4M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Ra Pharmaceuticals, Inc. Common Stock, an estimated $49.9M trimmed.

  • Candriam SCA's largest Q4 2019 buy was Vipshop: 2,005,000 shares worth $28.4M.
  • Candriam SCA added most to Microsoft in Q4 2019, an estimated $50.3M increase.
  • Candriam SCA's biggest Q4 2019 reduction was Ra Pharmaceuticals, Inc. Common Stock, cutting an estimated $49.9M.
  • Candriam SCA fully exited Hilton Worldwide in Q4 2019, selling an estimated $11.8M.
  • Candriam SCA's ten largest holdings make up 21% of its $9.33B portfolio in Q4 2019.
  • Candriam SCA opened 78 new positions and closed 33 in Q4 2019.
  • Candriam SCA's portfolio value rose 24% quarter-over-quarter to $9.33B.

Based on Candriam SCA's 13F filing for Q4 2019, filed 21 Jan 2020.